Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection

SARS‐CoV‐2 acute respiratory distress syndrome (ARDS) induces uncontrolled lung inflammation and coagulopathy with high mortality. Anti‐viral drugs and monoclonal antibodies reduce early COVID‐19 severity, but treatments for late‐stage immuno‐thrombotic syndromes and long COVID are limited. Serine p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liqiang, Li, Yize (Henry), Kibler, Karen, Kraberger, Simona, Varsani, Arvind, Turk, Julie, Elmadbouly, Nora, Aliskevich, Emily, Spaccarelli, Laurel, Estifanos, Bereket, Enow, Junior, Zanetti, Isabela Rivabem, Saldevar, Nicholas, Lim, Efrem, Schlievert, Jessika, Browder, Kyle, Wilson, Anjali, Juan, Fernando Arcos, Pinteric, Aubrey, Garg, Aman, Monder, Henna, Saju, Rohan, Gisriel, Savanah, Jacobs, Bertram, Karr, Timothy L, Florsheim, Esther Borges, Kumar, Vivek, Wallen, John, Rahman, Masmudur, McFadden, Grant, Hogue, Brenda G, Lucas, Alexandra R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493584/
https://www.ncbi.nlm.nih.gov/pubmed/37534622
http://dx.doi.org/10.15252/emmm.202317376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493584/
https://www.ncbi.nlm.nih.gov/pubmed/37534622
http://dx.doi.org/10.15252/emmm.202317376

Ejemplares similares